Welcome to BioRN

About 80 companies from the field of red biotechnology develop drugs, technology platforms and diagnostics at the Biotech Cluster Rhine-Neckar (BioRN). Globally acting healthcare companies as well as internationally renowned research institutes also play a significant  part in this development.

With its focus on personalized medicine and cancer research the BioRN cluster occupies a leading position in Germany. In 2008 it was awarded the leading-edge cluster for “Cell based and molecular medicine in the Rhine-Neckar Metropolitan Region”

News

September 28, 2014
Roche's Perjeta regimen extended the lives of people with an aggressive type of metastatic breast cancer by 15.7 months compared to Herceptin and chemotherapy
» [mehr]

September 26, 2014
DKFZ: Cancer Core Europe: a consortium to address the cancer care – cancer research continuum challenge
» [mehr]

September 26, 2014
Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of ‘Precision Medicine in Cancer Care’
» [mehr]

Newsletter

Read our monthly BioRN Newsletter. It will keep you informed about what´s going on in the BioRN cluster.

Events

» Find further future events here

HAE R&D Community

Increase your chances of getting your R&D project funded